Southpoint Capital Advisors Lp, Ten Percent Owner at Seelos Therapeutics, holds 3.67M shares in Seelos Therapeutics (Ticker: SEEL), holds 4.08M shares in Fennec Pharmaceuticals (Ticker: FENC), holds 450.00K shares in Lisata Therapeutics (Ticker: LSTA). Most recently, Southpoint Capital Advisors Lp ― shares of Seelos Therapeutics on ― for an estimated value of ―.
Southpoint Capital Advisors Lp insider profile FAQ
What is the percentage of profitable transactions made by Southpoint Capital Advisors Lp?
The percentage of profitable transactions made by Southpoint Capital Advisors Lp is ―.
What is the average return per transaction made by Southpoint Capital Advisors Lp?
The average return per transaction made by Southpoint Capital Advisors Lp is ―.
What stocks does Southpoint Capital Advisors Lp hold?
Southpoint Capital Advisors Lp holds: SEEL, FENC, LSTA stocks.
What was Southpoint Capital Advisors Lp’s latest transaction?
Southpoint Capital Advisors Lp latest transaction was an Uninformative Buy of ―.
What was Southpoint Capital Advisors Lp's most profitable transaction?
Southpoint Capital Advisors Lp’s most profitable transaction was an Informative Buy of FENC stock on May 6, 2020. The return on the trade was -3.70%.
What is Southpoint Capital Advisors Lp's role in Seelos Therapeutics?
Southpoint Capital Advisors Lp's role in Seelos Therapeutics is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.